Dorsey Wright & Associates Novartis Ag Transaction History

Dorsey Wright & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$78.07 - $94.43 $2.6 Million - $3.14 Million	-33,287 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$82.14 - $91.0 $38,441 - $42,588	468 Added 1.43%	33,287 $2.9 Million
Q2 2020 Jul 23, 2020	SELL	$80.93 - $91.1 $214,059 - $240,959	-2,645 Reduced 7.46%	32,819 $2.88 Million
Q1 2020 Apr 20, 2020	BUY	$70.67 - $99.01 $725,003 - $1.02 Million	10,259 Added 40.7%	35,464 $2.92 Million
Q4 2019 Jan 31, 2020	SELL	$84.35 - $95.37 $1.46 Million - $1.65 Million	-17,305 Reduced 40.71%	25,205 $2.39 Million
Q3 2019 Oct 31, 2019	SELL	$85.54 - $94.26 $54,574 - $60,137	-638 Reduced 1.48%	42,510 $3.7 Million
Q2 2019 Jul 02, 2019	SELL	$75.4 - $92.8 $210,064 - $258,540	-2,786 Reduced 6.07%	43,148 $3.94 Million
Q1 2019 Apr 04, 2019	BUY	$75.32 - $86.15 $3.46 Million - $3.96 Million	45,934 New	45,934 $4.42 Million

1,426

138M

1.48M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $245B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.